Wire · opportunities
Clinical Trial Evaluates Blood Test for Early Breast Cancer Detection Alongside Mammography
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 17 October 2026 · Fusion42 review
USC researchers are conducting a phase 1 clinical trial to evaluate a blood-based liquid biopsy that detects rare cancer-associated cells and large extracellular vesicles to identify early-stage breast cancer alongside mammography, aiming to improve detection and address mammography limitations.
This Wire brief sits within Fusion42's coverage of Medtech, and 2 sources have reported it between 15 Oct 2026 and 17 Oct 2026.
◆ ◆ The Wire takeaway
Your breast cancer early detection options are expanding beyond mammograms. If you work in diagnostics, integrating liquid biopsy signals could open new routes for screening hard-to-reach patients and those without mammography access.
◆ Coverage
2 sources · first reported 15 Oct 2026 · latest 17 Oct 2026
◆ Related on Wire
◆ Topics